Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse Dexamethasone in FSGS
NCT00004990Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in focal segmental glomerulosclerosis (FSGS), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 2000; status: completed.
02
Drugs
dexamethasone
03
Conditions
focal segmental glomerulosclerosis (FSGS)
Beyond the preview
Go deeper on NCT00004990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004990.